i
Preventing venous thromboembolism
-
January 15, 2013
-
Details:
-
Alternative Title:Patient safety and prevention of hospital-associated venous thromboembolism;Prevention of venous thromboembolism (VTE): the Johns Hopkins VTE Collaborative;Public health importance of venous thromboembolism;
-
Personal Author:
-
Corporate Authors:Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. ; National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention), Division of Blood Disorders. ; Centers for Disease Control and Prevention (U.S.). Office of Surveillance, Epidemiology and Laboratory Services., Public Health Informatics & Technology Program Office.
-
Description:This session of Grand Rounds will explore Venous Thromboembolism (VTE), which consists of 2 related conditions caused by blood clots: Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). Estimates of the number of people in the U.S. affected by a DVT/PE each year range from 350,000-900,000, with up to 100,000 dying as a result, and 20-50% of people who experience a DVT develop long-term complications. Up to one-half of all VTEs occur during or soon after hospitalizations, and VTE is one of the most frequent serious adverse events in hospitals. Many VTEs can be prevented if hospitals educate providers and patients, systematically assess risks for clotting and bleeding, and prescribe risk-appropriate prevention strategies. VTE prevention is an important component of hospital patient safety improvement efforts that are being supported by a number of organizations and Federal agencies. A comprehensive public health approach to VTE prevention includes activities to develop monitoring systems to evaluate and ensure widespread adoption of effective prevention strategies.
-
Content Notes:Streaming video (57:43. : sd., col.).
Presented by: Althea M. Grant, PhD, CDR, U.S. Public Health Service, Chief, Epidemiology and Surveillance Branch, Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC ["Public Health Importance of Venous Thromboembolism"]; Michael B. Streiff, MD, FACP, Associate Professor of Medicine, Medical Director, Johns Hopkins Anticoagulation Management Service, Johns Hopkins Medical Institutions ["Prevention of Venous Thromboembolism (VTE): The Johns Hopkins VTE Collaborative"]; P. Jeffrey Brady, MD, MPH, CPT, U.S. Public Health Service, Associate Director, Center for Quality Improvement and Patient Safety, Agency for Healthcare Research and Quality ["Patient Safety and Prevention of Hospital-Associated Venous Thromboembolism"]
Facilitated by: Tanja Popovic, MD, PhD, Scientific Director, Public Health Grand Rounds, John Iskander, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds, Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds
Recorded Tuesday, January 15, 2013.
Mode of access: World Wide Web as streaming video (565 MB, total time: 57:43); and as Acrobat .pdf files: (7.95 MB, 59 p.) containing PowerPoint slides for the speakers' talks.
Open-captioned.
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: